Clinical Trials Browser

Phase 1 × OTHER × tisagenlecleucel × Clear all

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04419909 2025-07-02

Retreatment With CTL019/CTL119

Phase 1 Not yet recruiting

12 enrolled

Lymphoid

Lymphoma, B-Cell

NCT02529813 2022-06-30

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Phase 1 Completed

26 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Retreatment With CTL019/CTL119

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies